Pharmacolog has delivered two demo systems to Codonics as a result of the recently established partnership agreement. Preparations for a more comprehensive launch of WasteLog® have also been initiated.
On December 4, 2020, Pharmacolog AB and Codonics Inc. entered into a long-term partnership agreement regarding sales and marketing of WasteLog® in the North American market. As part of the launch, Codonics Inc. has ordered the first two demo systems that have just been delivered. The companies are working on a launch plan for WasteLog in the North American market and training of Codonic’s sales organization will be carried out by Pharmacolog’s American organization in the coming month. The sale of the demo systems means a smaller impact on earnings.
Mats Högberg, CEO of Pharmacolog comments: “The first demo systems have arrived at Codonics and the planning of the launch campaign is in full swing. It is gratifying to see the strong commitment from Codonic. I am also happy that we have our own competent staff on site in the US now during the start-up. Especially as the pandemic makes it difficult for us from Sweden to travel to the United States.”
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.